Shares of Genpact Limited (NYSE:G - Get Free Report) have received a consensus recommendation of "Hold" from the eight research firms that are presently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $52.2857.
Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft assumed coverage on Genpact in a research report on Thursday, July 17th. They issued a "hold" rating and a $47.00 price objective for the company. Weiss Ratings reiterated a "hold (c)" rating on shares of Genpact in a report on Wednesday. Mizuho raised their price target on shares of Genpact from $48.00 to $51.00 and gave the stock a "neutral" rating in a report on Tuesday, July 1st. Needham & Company LLC boosted their price objective on shares of Genpact from $50.00 to $53.00 and gave the company a "buy" rating in a research report on Friday, August 8th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Genpact from $55.00 to $50.00 and set a "neutral" rating for the company in a report on Wednesday, August 20th.
Read Our Latest Analysis on G
Genpact Price Performance
Shares of NYSE:G opened at $40.66 on Thursday. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.32. The stock has a market cap of $7.09 billion, a PE ratio of 13.51, a PEG ratio of 1.40 and a beta of 0.89. The company's fifty day moving average is $43.11 and its 200 day moving average is $44.74. Genpact has a 52 week low of $37.82 and a 52 week high of $56.76.
Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The business services provider reported $0.88 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.85 by $0.03. Genpact had a return on equity of 22.15% and a net margin of 10.92%.The firm had revenue of $1.25 billion for the quarter, compared to analysts' expectations of $1.23 billion. During the same period last year, the firm earned $0.79 earnings per share. The company's revenue for the quarter was up 6.6% compared to the same quarter last year. Genpact has set its FY 2025 guidance at 3.510-3.580 EPS. Q3 2025 guidance at 0.890-0.900 EPS. Research analysts anticipate that Genpact will post 3.21 earnings per share for the current year.
Insider Buying and Selling
In other news, CEO Balkrishan Kalra sold 55,000 shares of Genpact stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $43.36, for a total transaction of $2,384,800.00. Following the sale, the chief executive officer owned 295,246 shares of the company's stock, valued at approximately $12,801,866.56. The trade was a 15.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Piyush Mehta sold 76,902 shares of the firm's stock in a transaction dated Friday, September 12th. The stock was sold at an average price of $42.58, for a total transaction of $3,274,487.16. Following the completion of the sale, the senior vice president owned 134,880 shares of the company's stock, valued at $5,743,190.40. This trade represents a 36.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. 3.07% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Genpact
Large investors have recently made changes to their positions in the business. Envestnet Portfolio Solutions Inc. boosted its holdings in Genpact by 59.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 10,355 shares of the business services provider's stock worth $522,000 after acquiring an additional 3,849 shares in the last quarter. Wealth Enhancement Advisory Services LLC boosted its stake in Genpact by 20.6% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 9,650 shares of the business services provider's stock worth $486,000 after purchasing an additional 1,651 shares in the last quarter. Wright Investors Service Inc. bought a new position in Genpact in the 2nd quarter worth about $457,000. GAMMA Investing LLC grew its position in Genpact by 88.0% during the 1st quarter. GAMMA Investing LLC now owns 9,744 shares of the business services provider's stock valued at $491,000 after purchasing an additional 4,561 shares during the last quarter. Finally, Assenagon Asset Management S.A. bought a new stake in Genpact during the 1st quarter valued at about $2,396,000. 96.03% of the stock is currently owned by hedge funds and other institutional investors.
Genpact Company Profile
(
Get Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.